. 2019 Nov 26;22:100708. doi: 10.1016/j.bbrep.2019.100708

Table 4.

Correlation between different parameters for patients group (n = 60).

		ER	PR	HER2neu	EMP2 Normal	EMP2 Malignant	β1- integrin Normal	β1- integrin Malignant
Age (years)	r	0.211	0.211	-0.246	0.285	-0.276	0.012	-0.252
Age (years)	P	0.264	0.264	0.190	0.126	0.140	0.951	0.178
Affected lymph node	r	0.350	0.350	-0.205	0.178	-0.225	0.171	-0.028
Affected lymph node	P	0.058	0.058	0.278	0.347	0.231	0.366	0.882
Molecular type	r	-0.914*	-0.914*	0.241	-0.397*	0.689*	-0.275	0.430*
Molecular type	P	<0.001*	<0.001*	0.200	0.030*	<0.001*	0.142	0.018*
Hb (g/dl)	r	0.154	0.154	0.198	-0.289	-0.144	0.072	-0.009
Hb (g/dl)	P	0.415	0.415	0.295	0.122	0.449	0.704	0.963
WBCs ( × 10³/μl)	r	0.153	0.153	-0.072	0.264	-0.024	0.256	-0.006
WBCs ( × 10³/μl)	P	0.419	0.419	0.706	0.158	0.899	0.172	0.973
Platelets ( × 10³/μl)	r	-0.222	-0.222	-0.075	-0.079	0.269	0.066	0.180
Platelets ( × 10³/μl)	P	0.239	0.239	0.694	0.678	0.151	0.728	0.341
CA 15–3 (IU/ml)	r	-0.009	-0.009	-0.071	0.150	-0.197	0.050	0.037
CA 15–3 (IU/ml)	P	0.964	0.964	0.708	0.430	0.297	0.792	0.844

r: Pearson coefficient, *: Statistically significant at p ≤ 0.05.